RIAS
IMNM icon

Rachor Investment Advisory Services’s Immunome IMNM Stock Holding History

Rachor Investment Advisory Services’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29
Closed -$635 – 305
2026
Q1 		$635 Hold
29
– – ﹤0.01% 361
2025
Q4 		$623 Buy
+29
New +$509 ﹤0.01% 338

Other funds holding IMNM

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Rachor Investment Advisory Services's IMNM Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Immunome (IMNM) in Q2 2026, closing a stake of 29 shares — an estimated $635 sold.

Rachor Investment Advisory Services first reported a position in IMNM in Q4 2025 and held it in 2 quarters. The position peaked at $635 in Q1 2026. 45 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 29 Immunome shares in Q2 2026, an estimated $635.
  • Rachor Investment Advisory Services first reported a position in Immunome in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Immunome position peaked at $635 in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.